Cited by 266Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

Reiman, Eric M., Uecker, Anne, Caselli, Richard J., Lewis, Stephen, Bandy, Daniel, De Leon, Mony J., De Santi, Susan, Convit, Antonio, Osborne, David, Weaver, Amy, Thibodeau, Stephen N.·1998·Annals of Neurology

DOI 10.1002/ana.410440226

Open this paper in CoChat — free account

Abstract

Brain imaging techniques have the potential to characterize neurobiological changes that precede the onset of cognitive impairment in persons at risk for Alzheimer's disease. As previously described, positron emission tomography (PET) was used to compare 11 cognitively normal persons 50 to 62 years of age who were homozygous for the ε4 allele of apolipoprotein E and 22 persons without the ε4 allele with a reported family history of Alzheimer's dementia who were matched for sex, age, and level of education. The ε4 homozygotes had significantly reduced glucose metabolism in the same brain regions as patients with Alzheimer's dementia; the largest reduction was in the posterior cingulate cortex. As described here, magnetic resonance imaging (MRI) was used to compare hippocampal volumes in the same subject groups. The ε4 homozygotes showed nonsignificant trends for smaller left and right hippocampal volumes; overall, smaller hippocampal volumes were associated with reduced performance on a long‐term memory test. Whereas PET measurements of cerebral glucose metabolism begin to decrease before the onset of memory decline, MRI measurements of hippocampal volume begin to decrease in conjunction with memory decline in cognitively normal persons at risk for Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1002/ana.410440226

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus
Zola-Morgan, S., Squire, L., & Amaral, D. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-10-02950.1986 · Cited by 1,997
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citation
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O’Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 880
Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., & Rossor, M. N. (1996) · Brain · doi:10.1093/brain/119.6.2001 · Cited by 656
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
Kesslak, J. P., Nalcioğlu, O., & Cotman, C. W. (1991) · Neurology · doi:10.1212/wnl.41.1.51 · Cited by 434
Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia
Laakso, M. P., Partanen, K. P. L., Riekkinen, P., Lehtovirta, M., Helkala, E.-L., Hallikainen, M., Hänninen, T., Vainio, P. A., & Soininen, H. S. (1996) · Neurology · doi:10.1212/wnl.46.3.678 · Cited by 433
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., De Santi, S., Mc Rae, T., Ferris, S. H., Reisberg, B., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00213-8 · Cited by 429
Self-citation
Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease
Convit, A., De Leon, M. J., Tarshish, C., De Santi, S., Tsui, W., Rusinek, H., & George, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00001-8 · Cited by 427
Self-citation

Show all 19 references

Research works printed but not linked: 1

Tsui WT, 1995, Multimodal image data analysis system (MIDAS), version 1.0

Sorted by citations

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
Doody, R. S., Stevens, J. E., Beck, C., Dubinsky, R., Kaye, J. A., Gwyther, L. P., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,708
The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition
Lupien, S. J., Maheu, F., Tu, M., Fiocco, A., & Schramek, T. E. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2007.02.007 · Cited by 1,474
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Structural Brain Changes in Aging: Courses, Causes and Cognitive Consequences
Fjell, A. M., & Walhovd, K. B. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.3.187 · Cited by 1,158
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Self-citation
Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 938
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease
Du, A. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.441 · Cited by 736
Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories
Pruessner, J. C. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.4.433 · Cited by 706
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
Portet, F. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.085332 · Cited by 652
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 633
Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease
Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Mosconi, L., Pupi, A., & de Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 616
Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis
Petten, C. K. V. (2004) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.04.006 · Cited by 615
Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467
Self-citation
Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging
Chételat, G., & Baron, J. (2003) · NeuroImage · doi:10.1016/s1053-8119(02)00026-5 · Cited by 455
MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders
Geuze, E., Vermetten, E., & Bremner, J. D. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001579 · Cited by 412
Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500579102 · Cited by 401
Self-citation
A Four-Dimensional Probabilistic Atlas of the Human Brain
Mazziotta, J. C., Toga, A. W., Evans, A. C., Fox, P. T., Lancaster, J. L., Zilles, K., Woods, R. P., Paus, T., Simpson, G., Pike, G. B., et al. (2001) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2001.0080401 · Cited by 384
MCI conversion to dementia and the APOE genotype
Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff‐Detto, V., Salmon, É., Baron, J., Cristofaro, M. T. D., Padovani, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147469.18313.3b · Cited by 347
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
Michaelson, D. M. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.015 · Cited by 331
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
Twamley, E. W., Ropacki, S., & Bondi, M. W. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060863 · Cited by 291
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
Tondelli, M., Wilcock, G. K., Nichelli, P., de Jager, C. A., Jenkinson, M., & Zamboni, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.018 · Cited by 265
Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction
Ungar, L., Altmann, A., & Greicius, M. D. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9272-x · Cited by 246
LEAP: Learning embeddings for atlas propagation
Wolz, R., Aljabar, P., Hajnal, J. V., Hammers, A., & Rueckert, D. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.069 · Cited by 241
Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study
Honea, R. A., Vidoni, E. D., Harsha, A., & Burns, J. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1163 · Cited by 233
Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers
Burggren, A. C., Zeineh, M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., & Bookheimer, S. Y. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.039 · Cited by 225
Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia
Hsu, Y., Schuff, N. W., Du, A., Mark, K. E., Zhu, X., Hardin, D., & Weiner, M. W. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10163 · Cited by 217
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study
Trivedi, M. A., Schmitz, T. W., Ries, M. L., Torgerson, B. M., Sager, M. A., Hermann, B. P., Asthana, S., & Johnson, S. C. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-1 · Cited by 215
Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study
O’Dwyer, L., Lamberton, F., Matura, S., Tanner, C. J., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., & Hampel, H. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048895 · Cited by 199
Early detection of Alzheimer’s disease using neuroimaging
Mosconi, L., Bryś, M., Głodzik-Sobańska, L., Santi, S. D., Rusinek, H., & de Leon, M. J. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.016 · Cited by 196
Effects of Apolipoprotein E Genotype on Spatial Attention, Working Memory, and Their Interaction in Healthy, Middle-Aged Adults: Results From the National Institute of Mental Health's BIOCARD Study.
Greenwood, P. M., Lambert, C., Sunderland, T., & Parasuraman, R. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.2.199 · Cited by 188
Familial risk for Alzheimer's disease alters fMRI activation patterns
Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., & Zeger, S. L. (2006) · Brain · doi:10.1093/brain/awl089 · Cited by 174
Temporal lobe morphology in normal aging and traumatic brain injury.
Bigler, E. D., Anderson, C. V., Blatter, D. D., & Andersob, C. V. (2002) · PubMed Central · Cited by 168
Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease
Protas, H. D., Chen, K., Langbaum, J. B. S., Fleisher, A. S., Alexander, G. E., Lee, W., Bandy, D., de Leon, M. J., Mosconi, L., Buckley, S., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.286 · Cited by 161
Self-citation
Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
Celsis, P. (2000) · Annals of Medicine · doi:10.3109/07853890008995904 · Cited by 173
Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele
Wishart, H. A., Saykin, A. J., McAllister, T. W., Rabin, L. A., McDonald, B. C., Flashman, L. A., Roth, R. M., Mamourian, A. C., Tsongalis, G. J., & Rhodes, C. H. (2006) · Neurology · doi:10.1212/01.wnl.0000238079.00472.3a · Cited by 158
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease
Dickerson, B. C., & Sperling, R. A. (2005) · Neurotherapeutics · doi:10.1602/neurorx.2.2.348 · Cited by 159
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype
Mishra, S., Blazey, T. M., Holtzman, D. M., Cruchaga, C., Su, Y., Morris, J. C., Benzinger, T. L. S., & Gordon, B. A. (2018) · Brain · doi:10.1093/brain/awy103 · Cited by 151
Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157
Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E
Mayeux, R. P., Small, S. A., Tang, M., Tycko, B., & Stern, Y. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00223-8 · Cited by 156
APOE Genotype and Neuroimaging Markers of Alzheimer’s Disease: Systematic Review and Meta-Analysis
Liu, Y., Yu, J.-T., Wang, H.-F., Han, P.-R., Tan, C.-C., Wang, C., Meng, X.-F., Risacher, S. L., Saykin, A. J., & Tan, L. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307719 · Cited by 152
The APOE ɛ4 allele modulates brain white matter integrity in healthy adults
Heise, V, Filippini, N., Ebmeier, K. P., & Mackay, C. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.90 · Cited by 152
Biomarkers for Alzheimer’s Disease Early Diagnosis
Ausó, E., Gómez‐Vicente, V., & Esquiva, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030114 · Cited by 159
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
Caroli, A., & Frisoni, G. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.024 · Cited by 150
The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation
Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., Asthana, S., Hermann, B. P., & Sager, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0959-06.2006 · Cited by 154
MEDITERRANEAN DIET AND MAGNETIC RESONANCE IMAGING-ASSESSED BRAIN ATROPHY IN COGNITIVELY NORMAL INDIVIDUALS AT RISK FOR ALZHEIMER’S DISEASE
Mosconi, L., Murray, J., Tsui, W. H., Li, Y., Davies, M., Williams, S., Pirraglia, E., Spector, N. C., Osorio, R. S., Glodzik, L., et al. (2014) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2014.17 · Cited by 143
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging☆
Schuff, N. W., Amend, D. L., Knowlton, R. K., Norman, D. M., Fein, G., & Weiner, M. W. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00022-6 · Cited by 142
Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4
Espeseth, T., Westlye, L. T., Fjell, A. M., Walhovd, K. B., Rootwelt, H., & Reinvang, I. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.030 · Cited by 135
A Review of the Brain Structure Correlates of Successful Cognitive Aging
Kaup, A. R., Mirzakhanian, H., Jeste, D. V., & Eyler, L. T. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.1.jnp6 · Cited by 146
The Association between a Polygenic Alzheimer Score and Cortical Thickness in Clinically Normal Subjects
Sabuncu, M. R., Buckner, R. L., Smoller, J. W., Lee, P. H., Fischl, B. R., & Sperling, R. A. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr348 · Cited by 134
Genetics and visual attention: Selective deficits in healthy adult carriers of the ɛ4 allele of the apolipoprotein E gene
Greenwood, P. M., Sunderland, T., Friz, J., & Parasuraman, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11661 · Cited by 136
Exercise, APOE genotype, and the evolution of the human lifespan
Raichlen, D. A., & Alexander, G. E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.03.001 · Cited by 132
The apolipoprotein E gene, attention, and brain function.
Parasuraman, R., Greenwood, P. M., & Sunderland, T. (2002) · Neuropsychology · doi:10.1037//0894-4105.16.2.254 · Cited by 134
Mapping the Alzheimer’s Brain with Connectomics
Xie, T., & Yong He, A. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00077 · Cited by 129
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume
Lupton, M. K., Strike, L. T., Hansell, N. K., Wen, W. X., Mather, K. A., Armstrong, N. J., Thalamuthu, A., McMahon, K. L., de Zubicaray, G. I., Assareh, A. A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.023 · Cited by 125
Aerobic fitness relates to learning on a virtual Morris Water Task and hippocampal volume in adolescents
Herting, M. M., & Nagel, B. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.012 · Cited by 137
Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes
Caselli, R. J., Graff‐Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J. A., Uecker, A., & Thibodeau, S. N. (1999) · Neurology · doi:10.1212/wnl.53.1.201 · Cited by 120
Self-citation
Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years
Mondadori, C. R. A., Buchmann, A., Mustovic, H., Schmidt, C. F., Boesiger, P., Nitsch, R. M., Höck, C., Streffer, J. R., & Henke, K. (2006) · Brain · doi:10.1093/brain/awl266 · Cited by 121
Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates
Chen, K., Reiman, E. M., Alexander, G. E., Caselli, R. J., Gerkin, R. D., Bandy, D. J., Domb, A., Osborne, D., Fox, N. C., Crum, W. R., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.916 · Cited by 121
Self-citation
Brain function and cognition in a community sample of elderly Latinos
Jagust, W. J., Eberling, J. L., Wu, C. C., Finkbeiner, A., Mungas, D., Valk, P. E., & Haan, M. N. (2002) · Neurology · doi:10.1212/wnl.59.3.378 · Cited by 118
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T
Mueller, S. G., Schuff, N., Raptentsetsang, S., Elman, J., & Weiner, M. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.174 · Cited by 116
Predicting the progression of mild cognitive impairment using machine learning: a systematic, quantitative and critical review
Ansart, M., Epelbaum, S., Bassignana, G., Bône, A., Bottani, S., Cattai, T., Couronné, R., Faouzi, J., Koval, I., Louis, M., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101848 · Cited by 116
Neuroimaging as a marker of the onset and progression of Alzheimer's disease
Masdeu, J. C., Zubieta, J. L., & Arbizu, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.001 · Cited by 114
Segmentation of the hippocampus by transferring algorithmic knowledge for large cohort processing
Thyreau, B., Sato, K., Fukuda, H., & Taki, Y. (2017) · Medical Image Analysis · doi:10.1016/j.media.2017.11.004 · Cited by 113
Amygdala–hippocampal volume and verbal memory in first-degree relatives of schizophrenic patients
O’Driscoll, G. A., Florencio, P. S., Gagnon, D., Wolff, A.-L. V. G., Benkelfat, C., Mikula, L., Lal, S., & Evans, A. C. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00095-6 · Cited by 108
Normal Genetic Variation, Cognition, and Aging
Greenwood, P. M., & Parasuraman, R. (2003) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582303260641 · Cited by 110
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease
Honea, R. A., Swerdlow, R. H., Vidoni, E. D., Goodwin, J., & Burns, J. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c918cb · Cited by 106
Does Alzheimer’s Disease Affect Hippocampal Asymmetry? Evidence from a Cross-Sectional and Longitudinal Volumetric MRI Study
Barnes, J., Scahill, R. I., Schott, J. M., Frost, C. D., Rossor, M. N., & Fox, N. C. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084560 · Cited by 108
Differential Cross-Sectional and Longitudinal Impact of APOE Genotype on Hippocampal Volumes in Nondemented Older Adults
Jak, A. J., Houston, W. S., Nagel, B. J., Corey‐Bloom, J., & Bondi, M. W. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101340 · Cited by 107
Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies
Devous, M. D. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0967-2 · Cited by 103
APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive Aging
Bookheimer, S. Y., & Burggren, A. C. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153625 · Cited by 108
Structural correlates of mild cognitive impairment
Wolf, H., Hensel, A., Kruggel, F., Riedel-Heller, S. G., Arendt, T., Wahlund, L., & Gertz, H. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.006 · Cited by 107
Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease
Wierenga, C. E., & Bondi, M. W. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9025-y · Cited by 105
Hippocampal volumes are important predictors for memory function in elderly women
Ystad, M. A., Lundervold, A. J., Wehling, E. I., Espeseth, T., Rootwelt, H., Westlye, L. T., Andersson, M., Adólfsdóttir, S., Geitung, J. T., Fjell, A. M., et al. (2009) · BMC Medical Imaging · doi:10.1186/1471-2342-9-17 · Cited by 102
No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects
Lemaître, H., Crivello, F., Dufouil, C., Grassiot, B., Tzourio, C., Alpérovitch, A., & Mazoyer, B. M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.016 · Cited by 102
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
Chauhan, G., Adams, H. H. H., Bis, J. C., Weinstein, G., Yu, L., Töglhofer, A. M., Smith, A. V., van der Lee, S. J., Gottesman, R. F., Thomson, R. J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.028 · Cited by 98
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 101
Natural history of Alzheimer’s disease
Honig, L. S., & Mayeux, R. P. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351476 · Cited by 98
Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk
Corlier, F. W., Hafzalla, G. W., Faskowitz, J., Kuller, L. H., Becker, J. T., López, O. L., Thompson, P. M., & Braskie, M. N. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2017.12.027 · Cited by 103
Effect of parental family history of Alzheimer's disease on serial position profiles
Rue, A. L., Hermann, B. P., Jones, J. E., Johnson, S. C., Asthana, S., & Sager, M. A. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.03.009 · Cited by 100
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies
Mistur, R. L., Mosconi, L., Santi, S. D., Guzman, M., Li, Y., Tsui, W., & de Leon, M. J. (2009) · Journal of Clinical Neurology · doi:10.3988/jcn.2009.5.4.153 · Cited by 101
Neuroimaging and APOE Genotype: A Systematic Qualitative Review
Cherbuin, N., Leach, L., Christensen, H. M., & Anstey, K. J. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000109150 · Cited by 93
Mild cognitive impairment: Conceptual issues and structural and functional brain correlates
Saykin, A. J., & Wishart, H. A. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50002 · Cited by 93
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele
Mori, E., Lee, K., Yasuda, M., Hashimoto, M., Kazui, H., Hirono, N., & Matsui, M. (2002) · Annals of Neurology · doi:10.1002/ana.10093 · Cited by 91
Delayed recall, hippocampal volume and Alzheimer neuropathology
Mortimer, J. A., Gosche, K. M., Riley, K. P., Markesbery, W. R., & Snowdon, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000106463.66966.65 · Cited by 92
Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people
Williams, J. H. H. (2002) · Age and Ageing · doi:10.1093/ageing/31.6.440 · Cited by 89
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts
Khan, W., Westman, E., Jones, N., Wahlund, L., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Soininen, H. S., Spenger, C., et al. (2014) · Brain Topography · doi:10.1007/s10548-014-0415-1 · Cited by 88
Imaging is superior to cognitive testing for early diagnosis of Alzheimer’s disease
ZAMRINI, E. Y., Santi, S. D., & Tolar, M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.009 · Cited by 88
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes
Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85
Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan
Fouquet, M., Besson, F. L., Gonneaud, J., Joie, R. L., & Chételat, G. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9263-8 · Cited by 89
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults
Alexander, G. E., Bergfield, K. L., Chen, K., Reiman, E. M., Hanson, K. D., Lin, L., Bandy, D. J., Caselli, R. J., & Moeller, J. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.014 · Cited by 91
Self-citation
Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease
Kantarci, K., & Jack, C. R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.196 · Cited by 80
Alzheimer Disease
Caselli, R. J., Beach, T. G., Knopman, D. S., & Graff-Radford, N. R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.011 · Cited by 81
Self-citation
Dementia, quantitative neuroimaging, and apolipoprotein E genotype.
Bigler, E. D., Lowry, C. M., Anderson, C. V., Johnson, S. C., Terry, J., & Steed, M. (2000) · PubMed Central · Cited by 78
Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve
Mosconi, L. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.030882 · Cited by 76

Authors: Reiman, E. M., Uecker, A., Caselli, R. J., Lewis, S., Bandy, D., De Leon, M. J., De Santi, S., Convit, A., Osborne, D., Weaver, A., & Thibodeau, S. N.
Affiliations: University of Arizona (US)
Mayo Clinic (US)
Good Samaritan Regional Medical Center (US)
NYU Langone Health (US)
Corresponding author: Reiman, Eric M.
ORCID: Reiman, Eric M.
Caselli, Richard J.
Lewis, Stephen
Convit, Antonio
Weaver, Amy
Thibodeau, Stephen N.
Venue: Annals of Neurology
Publisher: Wiley
Published: 1998-08
Volume: 44
Issue: 2
Pages: 288-291
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.410440226
OpenAlex: W1996433268
Cited by: 266
References: 19
Citations by year: 2026: 2 · 2025: 1 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 14 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 15 · 2013: 7 · 2012: 13
FWCI: 9.36
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2260 d)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG 12101, R01AG013616, AG 13616)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: hippocampal volume, Alzheimer's disease, APOE ε4, genetic risk, cognitively normal elderly, family history of dementia, brain glucose metabolism, posterior cingulate cortex, long-term memory, hippocampal atrophy, early detection of cognitive decline
MeSH terms: Aged, Alleles, Alzheimer Disease, Apolipoproteins E, Carrier State, Genotype, Hippocampus, Humans, Functional Laterality, Magnetic Resonance Imaging, Middle Aged, Neuropsychological Tests, Reference Values, Sensitivity and Specificity, Chi-Square Distribution, Logistic Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks